 |
Pharmaceutical Formulation
IriSys tailors the formulation to the drug’s physical
and chemical characteristics, each formulation is unique to the
compound. The Company provides world-class dosage form development services, both classical and proprietary. IriSys’ team
understands the long term benefits and advantages of various dosage
form technologies for small molecules, peptides and proteins. The
staff of prominent leaders from academia and industry combine expertise
in every facet of dosage form development including requirements
of the Chemistry, Manufacturing and Controls (CMC) section of the
Investigational New Drug application (IND). IriSys offers
the capability of bringing new products to the market quickly and
efficiently. Novel formulations are a consideration when
requested for patent extension purposes.
IriSys develops formulations
for new chemical entities, OTC products, generic products, and
505(b)(2) product candidates. The company
develops the following dosage forms.
- Tablets
- Capsules, powder-filled
- Capsules, liquid-filled
- Oral solutions and suspensions
- Topical products
- Injectables
- Controlled release products
- Sustained release products
- Pellets
- Microspheres
- Lyophilized products
- Animal study materials
|
|
